Literature DB >> 15264270

Familial Wilms tumor.

E Cristy Ruteshouser1, Vicki Huff.   

Abstract

Wilms tumor (WT), an embryonic tumor arising from undifferentiated renal mesenchyme, has been a productive model for understanding the role of genes in both tumorigenesis and normal organogenesis. Approximately 2% of WT patients have a family history of WT, and even sporadic WT is thought to have a strong genetic component to its etiology. Familial WT cases generally have an earlier age of onset and an increased frequency of bilateral disease, although there is variability among WT families, with some families displaying later than average ages at diagnosis. One WT gene, WT1 at 11p13, has been cloned, but only a minority of tumors carry detectable mutations at that locus, and it can be excluded as the predisposition gene in most WT families. Two familial WT genes have been localized, FWT1 at 17q12-q21 and FWT2 at 19q13.4; lack of linkage in some WT families to either of these loci implies the existence of at least one additional familial WT gene. Originally modeled as the inheritance of a mutation in a tumor suppressor gene, molecular analysis of familial tumors not linked to 11p13 have provided data suggesting that this model may be overly simplistic and/or not applicable to all WT families. Identification of the FWT1 and FWT2 genes will help clarify this and will also likely aid in our understanding in general of the roles of the various WT genes and their genetic interactions in the development of WT. Copyright 2004 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2004        PMID: 15264270     DOI: 10.1002/ajmg.c.30025

Source DB:  PubMed          Journal:  Am J Med Genet C Semin Med Genet        ISSN: 1552-4868            Impact factor:   3.908


  11 in total

Review 1.  Current management of wilms' tumor.

Authors:  Leah Nakamura; Michael Ritchey
Journal:  Curr Urol Rep       Date:  2010-02       Impact factor: 3.092

2.  Prenatal exposure to air toxics and risk of Wilms' tumor in 0- to 5-year-old children.

Authors:  Anshu Shrestha; Beate Ritz; Michelle Wilhelm; Jiaheng Qiu; Myles Cockburn; Julia E Heck
Journal:  J Occup Environ Med       Date:  2014-06       Impact factor: 2.162

3.  Development of anaplastic Wilms tumor and subsequent relapse in a child with diaphanospondylodysostosis.

Authors:  Sarah K Tasian; Grace E Kim; Douglas N Miniati; Steven G DuBois
Journal:  J Pediatr Hematol Oncol       Date:  2012-10       Impact factor: 1.289

4.  K-Ras, H-Ras, N-Ras and B-Raf mutation and expression analysis in Wilms tumors: association with tumor growth.

Authors:  Efterpi Dalpa; Victor Gourvas; Nikolaos Soulitzis; Demetrios A Spandidos
Journal:  Med Oncol       Date:  2016-12-09       Impact factor: 3.064

5.  Fetal programming and Wilms tumor.

Authors:  Julia E Heck; Di He; Carla Janzen; Noah Federman; Jorn Olsen; Beate Ritz; Johnni Hansen
Journal:  Pediatr Blood Cancer       Date:  2018-09-25       Impact factor: 3.167

6.  Wilms tumor genetics: mutations in WT1, WTX, and CTNNB1 account for only about one-third of tumors.

Authors:  E Cristy Ruteshouser; Stephen M Robinson; Vicki Huff
Journal:  Genes Chromosomes Cancer       Date:  2008-06       Impact factor: 5.006

7.  A high incidence of WT1 abnormality in bilateral Wilms tumours in Japan, and the penetrance rates in children with WT1 germline mutation.

Authors:  Y Kaneko; H Okita; M Haruta; Y Arai; T Oue; Y Tanaka; H Horie; S Hinotsu; T Koshinaga; A Yoneda; Y Ohtsuka; T Taguchi; M Fukuzawa
Journal:  Br J Cancer       Date:  2015-03-17       Impact factor: 7.640

8.  Family history of cancer and the risk of childhood solid tumours: a Norwegian nationwide register-based cohort study.

Authors:  Ruby Del Risco Kollerud; Karl Gerhard Blaasaas; Bjørgulf Claussen; Per Nafstad; Lisa A Cannon-Albright; Ellen Ruud; Finn Wesenberg; Øyvind Næss
Journal:  Br J Cancer       Date:  2018-02-20       Impact factor: 7.640

Review 9.  Wilms' Tumor Protein 1 and Enzymatic Oxidation of 5-Methylcytosine in Brain Tumors: Potential Perspectives.

Authors:  Ashley Ramsawhook; Alexey Ruzov; Beth Coyle
Journal:  Front Cell Dev Biol       Date:  2018-03-22

10.  ALDH1A2 (RALDH2) genetic variation in human congenital heart disease.

Authors:  Marilene Pavan; Viviane F Ruiz; Fábio A Silva; Tiago J Sobreira; Roberta M Cravo; Michelle Vasconcelos; Lívia P Marques; Sonia M F Mesquita; José E Krieger; Antônio A B Lopes; Paulo S Oliveira; Alexandre C Pereira; José Xavier-Neto
Journal:  BMC Med Genet       Date:  2009-11-03       Impact factor: 2.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.